Navigation Links
Codexis Interim Chief Executive Officer to Present at Jefferies Conference
Date:2/21/2012

REDWOOD CITY, Calif., Feb. 21, 2012 /PRNewswire/ -- Codexis, Inc. (Nasdaq: CDXS), a developer of industrial enzymes to enable the production of biofuels, bio-based chemicals, and pharmaceutical intermediates, today announced that Peter Strumph, interim Chief Executive Officer, will be presenting at the Jefferies Global Clean Technology Conference, to be held in New York, NY on Thursday, February 23, 2012 at 1:45 p.m. ET. A live webcast and replay will be available in the Investor section of www.codexis.com.

Codexis, Inc. is a developer of industrial enzymes to enable the production of biofuels, bio-based chemicals and pharmaceutical intermediates.  Codexis' product lines include CodeXyme™ Cellulase Enzymes and CodeXol™ Detergent Alcohol.  Partners and customers include global leaders such as Shell, Merck and Pfizer.  For more information, see www.codexis.com.  

Contacts: 
Investors: Jay Sarwar, ir@codexis.com, 650-421-8126
Media: Wes Bolsen, wes.bolsen@codexis.com, 650-421-8100


'/>"/>
SOURCE Codexis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Codexis to Present at the Pacific Crest and Jefferies Conferences
2. Codexis Names Wes Bolsen VP and Chief Marketing Officer
3. Shell Transfers Its Codexis Shares to Raizen
4. Codexis Reports First Quarter 2011 Results
5. Former Senator Byron Dorgan Elected to Codexis Board
6. Codexis Reports Fourth Quarter and Full Year 2010 Results
7. Codexis Grows Revenue 35 Percent in Third Quarter; Raises 2010 Outlook
8. Codexis Names Vonnie Estes to New Technology Strategic Planning VP Role
9. Codexis R&D Productivity Panels Also Used By Roche
10. Codexis Names Lori Giver VP Systems Biology
11. Codexis, Teva in Licensing Agreement Final
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... 22, 2017   Boston Biomedical , an industry ... to target cancer stemness pathways, today announced its Board ... as Chief Executive Officer, effective April 24, 2017. ... Li , M.D., FACP, who has led Boston Biomedical ... his leadership, Boston Biomedical has grown from a "garage ...
(Date:3/22/2017)... ... March 21, 2017 , ... Benchworks CEO ... Executive Officer Forum on March 23-24 in San Diego. The event is a ... diagnostic industries. , Benchworks Vice President Christian Meyer will also participate in the ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Society for Immunotherapy of Cancer ... in the Administration’s recently published fiscal year 2018 budget request. , This ... (NIH) by $5.8 billion or roughly 20% of its total budget. If applied proportionally ...
(Date:3/22/2017)... 2017   Invitae Corporation (NYSE: NVTA), ... today announced the availability of a new genetic ... Atrophy (SMA) , a neuromuscular disease that is ... infants as well as a significant cause of ... announced during the American College of Medical Genetics ...
Breaking Biology Technology:
(Date:2/28/2017)... , February 28, 2017 News solutions for ... ... from 14 to 16 March, Materna will present ... show how seamless travel is a real benefit for passengers. ... biometrics to their passenger touch point solutions to take passengers through ...
(Date:2/22/2017)... -- With the biometrics market to exceed $10 ... that innovative and agile startups must incorporate into ... changing competitive landscape: multifactor authentication (MFA), point-of-sale (PoS), ... "Companies can no longer afford to cut corners ... Pavlakis , Industry Analyst at ABI Research. "Pairing ...
(Date:2/13/2017)... 13, 2017  RSA Conference -- RSA, a Dell ... designed to enhance fraud detection and investigation across ... RSA Fraud & Risk Intelligence Suite. The new ... additional insights from internal and external sources as ... their customers from targeted cybercrime attacks. ...
Breaking Biology News(10 mins):